Why Skin Deposition is the Next Frontier in Skincare Globally
A Different Approach to Ingredient Performance: The NanoBase™ Architecture
Introduction: The Deposition Gap
In the global skincare market, the conversation has shifted from ingredient lists to performance metrics at the skin interface. Even the most potent cosmetic actives, retinoids, vitamin C derivatives, and peptides, face a significant hurdle: deposition, meaning how much active is retained at the skin interface, and where. Traditional emulsions often lack the structural support needed to keep these actives stable and effectively distributed. NanoBase™ enters the conversation not as a simple base, but as a lipid-based nano-colloidal Architecture designed for stability; any deposition claim belongs to the finished formula.
Beyond the Basics: The Evolution of Lipid Carriers
To understand where NanoBase™ fits, we must look at the documented trade-offs of existing high-performance routes:
• Liposomes: While pioneering, liposomes can face physical and chemical instability. Depending on composition and storage conditions, they are prone to structural changes and payload leakage.
• Solid Lipid Nanoparticles (SLNs): These offer protection for certain actives but are known for active expulsion. As lipids crystallize during storage, they can reduce entrapment of the payload, leading to inconsistent performance over time.
• Nanostructured Lipid Carriers (NLCs): These improved on SLNs by using a less ordered matrix to reduce expulsion risk. However, NLCs can be more demanding to scale consistently, because performance is sensitive to lipid composition, processing conditions, and QC controls.
NanoBase™: A Modern Nano-Colloidal Architecture
NanoBase™ is a nano-colloidal Architecture, a cosmetic raw material designed with lessons from lipid-carrier research. We engineered it to prioritize structural robustness and formulation compatibility, so labs running modern GMP workflows can avoid common pitfalls of traditional nanocarriers.
The Three Pillars of NanoBase™ Performance
Reduced Degradation Pathways: NanoBase™ is engineered to reduce common degradation pathways for delicate actives, including oxidative stress and ingredient-to-ingredient interactions within the formula.
Deposition hypothesis: The Zenodo preprint proposes that lipid matrix composition affects how cosmetic actives distribute at the skin interface; this hypothesis has not yet been tested, and NanoBase™ makes no deposition claim of its own.
Reduced Payload Drift Risk: Unlike some solid-lipid systems where crystallization over time can reduce entrapment, the NanoBase™ architecture is engineered to reduce payload drift risk during shelf life, supporting more consistent formulas from manufacture through use.
Engineering for Scale
For the modern founder, “best” now means performance you can measure. We frame NanoBase™ in terms of design specifications (a ~185 nm design target, DLS-characterised every batch) and stability, not marketing adjectives; deposition and retention are measured on finished formulas. Common validation routes include tape stripping, confocal Raman spectroscopy, and Franz diffusion cell studies, selected based on the active and the claim boundary. Outcomes vary by active chemistry, dose, and overall formula design.
By building on the NanoBase™ nano-colloidal Architecture, qualified contract manufacturers can offer clients a “hero product” built on measurable performance logic, designed for global cosmetic positioning.
